Exact Sciences Corp Q1 2023 Earnings Call Transcript - Thomson StreetEvents

Exact Sciences Corp Q1 2023 Earnings Call Transcript

Exact Sciences Corp Q1 2023 Earnings Call Transcript - Thomson StreetEvents
Exact Sciences Corp Q1 2023 Earnings Call Transcript
Published May 09, 2023
14 pages (9204 words) — Published May 09, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of EXAS.OQ earnings conference call or presentation 9-May-23 9:00pm GMT

  
Brief Excerpt:

...Operator Thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Exact Sciences Corporation Q1 2023 Conference Call. (Operator Instructions) With me now is Vice President, Investor Relations, Megan Jones. You may begin your conference. Megan Jones ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Exact Sciences Corp
Ticker
EXAS.OQ
Time
9:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division - Analyst : Congrats on the great quarter here and the cash flow news as well on EBITDA. So just a question on next-generation Cologuard. With this BLUE-C readout coming up pretty soon here, I'm just curious about precancer sensitivity, just given the importance of that metric as you included in a bunch of the DDW posters this past week, where I think you noted the threshold like 40% as like a baseline there. Do you think that the precancer sensitivity in BLUE-C, this is going to be like a game over for some of the emerging options. I mean, obviously, it probably means blood, but I mean that's kind of open-ended. And then just one other question on next-generation Cologuard. What's the path there for HEDIS since it took Cologuard a few years, but that's been a huge tailwind, I think? So would be curious to hear that.

Question: Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division - Analyst : Cologuard's next generation.

Table Of Contents

Exact Sciences Corp at William Blair Growth Stock Conference Summary – 2023-06-07 – US$ 54.00 – Edited Brief of EXAS.OQ presentation 7-Jun-23 8:20pm GMT

Exact Sciences Corp at Jefferies Healthcare Conference Summary – 2023-06-07 – US$ 54.00 – Edited Brief of EXAS.OQ presentation 7-Jun-23 6:00pm GMT

Exact Sciences Corp at William Blair Growth Stock Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 7-Jun-23 8:20pm GMT

Exact Sciences Corp at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 7-Jun-23 6:00pm GMT

Exact Sciences Corp at Bank of America Global Healthcare Conference Transcript – 2023-05-10 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 10-May-23 10:00pm GMT

Exact Sciences Corp at Raymond James Institutional Investors Conference Transcript – 2023-03-07 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 7-Mar-23 9:00pm GMT

Exact Sciences Corp at Cowen Health Care Conference Transcript – 2023-03-06 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 6-Mar-23 3:30pm GMT

Exact Sciences Corp at Citi Healthcare & Medtech Conference Transcript – 2023-03-01 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 1-Mar-23 7:45pm GMT

Exact Sciences Corp Q4 2022 Earnings Call Transcript – 2023-02-21 – US$ 54.00 – Edited Transcript of EXAS.OQ earnings conference call or presentation 21-Feb-23 10:00pm GMT

Exact Sciences Corp at JPMorgan Healthcare Conference Transcript – 2023-01-09 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 9-Jan-23 7:15pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Exact Sciences Corp Q1 2023 Earnings Call Transcript" May 09, 2023. Alacra Store. May 17, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2023-Exact-Sciences-Corp-Earnings-Call-T15542393>
  
APA:
Thomson StreetEvents. (2023). Exact Sciences Corp Q1 2023 Earnings Call Transcript May 09, 2023. New York, NY: Alacra Store. Retrieved May 17, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2023-Exact-Sciences-Corp-Earnings-Call-T15542393>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.